HAVCR2 and head and neck squamous cell carcinoma: We showed that TIM3 participates in the regulation of Tregs, and that blockade of TIM3 relieves the immune suppression by reducing Treg activation and decreasing CTLA4 and TIGIT in HNSCC, supporting the therapeutic value of anti-TIM3 treatment in HNSCC.